Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

Royalty Pharma plc

Intrinsic Value Analysis (Discounted Cash Flow)Industry: BiotechnologySector: Healthcare

Fair Value Summary

Current Price$38.38
5Y Range13.89 – 26.31
5Y Selected20.10
(-) Safety Margin79.81%
5Y Buy Price$4.06
Upside (to Buy Price)-89.42%
10Y Range13.85 – 24.84
10Y Selected19.34
(-) Safety Margin79.81%
10Y Buy Price$3.91
Upside (to Buy Price)-89.82%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.4155
Revenue R2 (10Y)0.8001
Net Income R2 (5Y)0.0110
Net Income R2 (10Y)0.0079
EBITDA R2 (5Y)0.0032
EBITDA R2 (10Y)0.0114
FCF R2 (5Y)0.7197
FCF R2 (10Y)0.8769
Safety Score0.2019

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth-6.36%-5.21%-4.06%-2.91%-1.76%-0.61%0.55%1.70%2.85%4.00%
Revenue2,119.552,009.091,927.521,871.461,838.581,827.441,837.421,868.601,921.831,998.70
EBITDA1,326.881,257.731,206.671,171.571,150.981,144.011,150.261,169.781,203.101,251.22
D&A-18.29-17.34-16.64-16.15-15.87-15.77-15.86-16.13-16.59-17.25
EBIT1,308.581,240.391,190.031,155.421,135.121,128.241,134.401,153.651,186.511,233.97
Pro forma Taxes0.000.000.000.000.000.000.000.000.000.00
NOPAT1,308.581,240.391,190.031,155.421,135.121,128.241,134.401,153.651,186.511,233.97
Capital Expenditures0.000.000.000.000.000.000.000.000.000.00
NWC Investment2.591.981.461.010.590.20-0.18-0.56-0.96-1.38
(+) D&A18.2917.3416.6416.1515.8715.7715.8616.1316.5917.25
Free Cash Flow1,329.461,259.711,208.131,172.581,151.571,144.211,150.081,169.221,202.141,249.84
Diluted Shares Outstanding572,152,750.00572,152,750.00572,152,750.00572,152,750.00572,152,750.00572,152,750.00572,152,750.00572,152,750.00572,152,750.00572,152,750.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 9.10%Terminal Growth: 2.40%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.880.810.740.680.620.570.520.48
PV UFCF1,317.941,210.251,063.90946.48852.01775.97714.90666.19627.83598.31
Raw: 17,605.58
12,470.84
Raw: 19,107.94
8,757.41

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value17,861.4317,531.19
(-) Net Debt7,152.637,152.63
Equity Value10,708.7910,378.56
(/) Shares Out572.15572.15
Fair Value$18.72$18.14
(-) Safety Margin79.81%79.81%
Buy Price$3.78$3.66
Current Price$38.38$38.38
Upside (to Buy Price)-90.15%-90.46%

Conservative Projected Flows

WACC: 10.10%Terminal Growth: 1.90%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.870.790.720.650.590.540.490.44
PV UFCF1,316.731,205.181,049.82925.47825.53745.02680.16628.06586.52553.86
Raw: 14,314.01
9,779.45
Raw: 15,535.48
6,561.17

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value15,102.2015,077.54
(-) Net Debt7,152.637,152.63
Equity Value7,949.577,924.91
(/) Shares Out572.15572.15
Fair Value$13.89$13.85
(-) Safety Margin79.81%79.81%
Buy Price$2.81$2.80
Current Price$38.38$38.38
Upside (to Buy Price)-92.69%-92.71%

Aggressive Projected Flows

WACC: 8.10%Terminal Growth: 2.90%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.890.830.760.710.650.600.560.52
PV UFCF1,319.151,215.391,078.30968.17879.60808.50751.77707.02672.48646.78
Raw: 22,796.89
16,747.79
Raw: 24,742.25
12,314.96

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value22,208.4021,362.11
(-) Net Debt7,152.637,152.63
Equity Value15,055.7614,209.47
(/) Shares Out572.15572.15
Fair Value$26.31$24.84
(-) Safety Margin79.81%79.81%
Buy Price$5.31$5.01
Current Price$38.38$38.38
Upside (to Buy Price)-86.16%-86.94%

Reverse DCF: Market Implied Growth

Current Price$38.38
WACC Used9.1%
IMPLIED REVENUE GROWTH167.38%
Metric2027202820292030203120322033203420352036
Implied Revenue6,283.0816,799.8744,919.97120,108.29321,148.92858,697.022,296,008.246,139,131.4016,414,982.1943,890,841.06
Constant Implied Growth167.38%167.38%167.38%167.38%167.38%167.38%167.38%167.38%167.38%167.38%
Implied Free Cash Flow0.631.684.4912.0132.1185.87229.60613.911,641.504,389.08
Discount Factor0.930.810.740.680.620.570.520.480.440.40
Present Value of Implied FCF0.581.363.328.1519.9648.93119.91293.88720.271,765.27

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$44.50-1.97%$47.947.73%
20182018-12-31$44.50-0.15%$55.3224.32%
20172017-12-31$44.500.91%$47.426.55%
20162016-12-31$44.504.79%$-6.96-115.63%
20152015-12-31$44.5012.67%$-7.03-115.80%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$18.86
Median
$18.04
10th Percentile
$13.72
90th Percentile
$25.17

Fair Value Distribution

$9.43 - $11.75
20
$11.75 - $14.07
95
$14.07 - $16.40
233
$16.40 - $18.72
201
$18.72 - $21.04
197
$21.04 - $23.36
103
$23.36 - $25.68
68
$25.68 - $28.01
40
$28.01 - $30.33
21
$30.33 - $32.65
9
$32.65 - $34.97
3
$34.97 - $37.29
4
$37.29 - $39.61
4
$39.61 - $41.94
0
$41.94 - $44.26
0
$44.26 - $46.58
1
$46.58 - $48.90
0
$48.90 - $51.22
0
$51.22 - $53.54
0
$53.54 - $55.87
1